Over the past 25 years, Express Pharma has been faithfully tracking and capturing the pulse of the life sciences industry. Be it policy and regulatory reforms or technological disruptions, therapeutic innovations or ground-breaking research, business strategies or blockbuster deals, it has been at the forefront in keeping readers abreast of the latest and future trends in this sector. At the same time, it has also served as a vehicle for key opinion leaders to convey their views and insights on the most pressing and topical issues faced by India’s pharma industry.
Express Pharma is exceedingly grateful to all its readers, champions and well-wishers for your continuous
support and trust. We hope and believe that you will continue to partner us in our mission to spur progress in this sector.
In continuance with that tradition, our anniversary special issues will comprise a diverse mix of articles, interviews and opinion pieces which will reflect on the many milestones achieved by India Pharma Inc and outline strategies to enable its next phase of growth:
Patient-centric innovation – catering to future needs
Manoj Saxena, Managing Director, Bayer Zydus Pharma, talks about how technology has become an essential tool that complements the personal and physical interaction with a healthcare professional to help patients lead a healthier life
The Indian Pharmaceutical Industry: Pride and Growth Lever of India
Sudarshan Jain, Secretary General, IPA and Archana Jatkar, Associate Secretary General, IPA reminisce on five significant steps which changed the course of India’s pharma industry and outline five steps that the industry needs to take for sustained growth over the next 25 years
“Patient-centric marketing will become a fundamental pillar in the future of pharma marketing”
Sumita Mohapatro Pani, Senior General Manager, Lupin speaks to Viveka Roychowdhury on the rewriting of the pharma sales and marketing playbook in the past two decades and highlights what makes pharma brand positioning so unique
Trends in retail pharma for 2020 and beyond
Arushi Jain, Executive Director, StayHappi Pharmacy explains how technological advancements would play a crucial role in the overall progression of the retail pharma industry
Encouraging patient-centric innovation in pharma
Dr Ayaaz Hussain Khan, Global Head Generics, Navitas Life Sciences (a TAKE Solutions Enterprise) emphasises that patient centricity should form the crux of pharma drug design and development
2020 and beyond: Key trends impacting the labelling market
Ken Moir, VP Marketing, NiceLabel highlights that there is a pipeline of new opportunities for global labelling solutions or label management systems